Hybrid Imaging, SPECT/CT and PET/CT encompasses not only the well-known nuclear medicine cameras (Single Photon Emission Computed Tomography, SPECT and Positron Emission Tomography, PET) but also the CT-camera (Computed Tomography, CT), which can be used as a device to determine the attenuation of the radiation emitted from the radiopharmaceutical within the patient making it possible […]
Patients workflows and acquisition protocols in PET/CT and PET/MR with different radiotracers for cardiovascular nuclear medicine imaging. Learning Objectives: To learn how to manage radioactive generators 82Sr/82Rb and to acquire cardiovascular imaging in PET/CT or PET/MR and other acquisition protocols. Faculty Registration Event Overview
A large oncological framework will be the topic of the first session: three lectures by a high quoted Paediatric Oncologist: epidemiology, aetiological factors, and general classification of Paediatric Hodgkin and non-Hodgkin Lymphomas and main therapeutic strategies and prognostic considerations. The two valuable nuclear medicine experts will discuss the role of molecular imaging in paediatric lymphomas: […]
General overview of the EANM/SNMMI guidelines on FDG PET/CT in inflammation and infection. Learning Objectives: The aim of this course is to summarize the major indications for FDG PET/CT in infection and inflammation, based on the updated guidelines for nuclear medicine practice provided by the EANM/SNMMI. Faculty Registration Event Overview
Radionuclide Theranostics is evolving and expanding in the field of nuclear medicine in various clinical settings. Its principle is based on therapeutic interventions after imaging to confirm the presence of a biological target. However, there are several clinical and technical challenges in setting up a successful theranostics team and facility. The common challenges include logistics, […]
Breast cancer is the most common cancer in women worldwide and it is still one of the leading causes of morbi-mortality, therefore being a major concern. 2-FDG PET/CT is commonly used in the clinical management of patients with breast cancer, with significant impact on clinical management. Currently, there is robust evidence supporting the usefulness of […]
The webinar will cover the most relevant methodological aspects of nuclear medicine techniques in paediatric nephrourology, with particular attention to the choice of the radiotracer, the correct patient preparation, and the acquisition protocol. Some typical cases will show the main points of image processing and results visualization. The clinical part will deal with hydronephrosis and […]
This course provides a comprehensive overview of nuclear medicine imaging of coronary artery disease. General aspects, details of radiotracers utilised, examination protocols and case examples of myocardial perfusion imaging (MPI) using PET and SPECT will be discussed at the event. The focus here will be on the quantification of data (e.g. abnormality scores, myocardial blood […]
The rapid development in machine learning has generated new artificial intelligence (AI) based methods for improving dosimetry within nuclear medicine. This webinar will present the current status of AI within the dosimetry workflow for targeted radionuclide therapy. First, AI methods for reducing SPECT acquisition times, noise reduction and scatter correction will be covered. Thereafter, AI […]
The course has a hybrid format with on-site lectures and hands-on practical and technic sessions, It will cover the basic and some advanced and future aspects of Radioguided surgery with a focus on the technologist's work and support the multidisciplinary team in charge of Radioguided procedures. Target Audience Learning Objectives Faculty Registration Details Event Overview
While PET imaging with radionuclides such as F18 and Ga68 have proven to provide high quality diagnostic imaging, imaging with other radionuclides can be more challenging. Zr-89 is one such radionuclide. Although Zr-89 has advantageous labelling properties for cell imaging and the imaging of monoclonal antibodies, the radionuclide is non-ideal imaging qualities mostly due to […]
The advent of FDA approved anti-AB drugs such as Aducanumab and Lecanemab is changing not only the therapeutic prospectives for patients but also the diagnostic flow-charts. However, due to differences in clinical processes and insurance systems in each country, the use of amyloid PET in the diagnostic tree currently varies from country to country. In Europe, […]
European School of Multimodality Imaging & Therapy (ESMIT)
Schmalzhofgasse 26
1060 Vienna
Austria
phone +43 1 890 44 27
e-mail esmit@eanm.org
